Sources

 
 

Fosamax News &
Announcements

07/02/2007 - Accident Raises Safety Concerns About Chinese Tires

Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature.

Read More

Schedule a Fosamax lawyer
consultation at no cost

  1. "Doctors Link Bisphosphonate Drugs, Used Against Osteoporosis and Cancer to Jawbone Necrosis." PSA Rising: Prostate Cancer Survivor. Ed. J. Strax. 2004. http://www.psa-rising.com/med/side_effects/osteo-necrosis.htm
  2. Marx, Robert E., et al. "Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment." Journal of Oral and Maxillofacial Surgery 63, II (Nov. 2005): 1567-1575.
  3. Selvin, Molly. "Lawyers Gear Up to Attack Fosamax." Los Angles Times 10 July 2006.
  4. Woo, Sook-bin, et al. "Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws." Annals of Internal Medicine. 144 (May 2006): 753-761.
  5. "Risk Factors for Bisphosphonate Associated Jaw Osteonecrosis." Johns Hopkins Arthritis. Johns Hopkins University. 2006. http://www.hopkins-arthritis.org/news-archive/2006/bisphosphonate_jaw_
    osteonecrosis.html.
  6. "Cases Against Merck For Fosamax Jaw Bone Damage Growing." Scoop International News. June 19, 2006. School of Medicine in the News. University of Miami Miller School of Medicine. http://www.med.miami.edu/communications/sum-news/index.asp?id=859.
  7. "Medications to Treat and Prevent Osteoporosis." National Institute of Arthritis and Musculoskeletal and Skin Diseases May 2006. http://www.niams.nih.gov/bone/hi/osteoporosis_medicine.htm.
  8. Boyles, Salynn. "Drug for Bone Disease Linked to 'Jaw Death'" WebMD Medical News. 3 Oct 2005. http://www.webmd.com/content/article/113/110591.htm.
  9. "Bisphosphonate Medications and Your Oral Health" American Dental Association. 2003. WebMD Medical News. 2006. http://www.webmd.com/content/article/124/115745.htm.
  10. Hamilton, Carey. "Fosamax Lawsuit Brings Risks to Light" The Salt Lake Tribune 20 June 2006. http://www.sltrib.com/ci_3957856.
  11. Purcell, Patrick M., Boyd, Ian W. "Bisphosphonates and Osteonecrosis of the Jaw." The Medical Journal of Australia 182 (2005): 417-418. http://www.mja.com.au/public/issues/182_08_180405/pur10144_fm.html
  12. Silverman, Ed. "Bone Building Drugs Linked to Bone Rotting Side Effect" Star Ledger. 13 July 2006. Parker & Waichman, LLP. 2006. http://www.yourlawyer.com/articles/read/118/11967.
  13. "Merck Accused of Negligence In Promotion of Osteoporosis Drug." Mealy's Mass Tort Pleadings 15 May 2006.
  14. Grady, Denise. "Osteoporosis Drug Found Safe to Take for 10 Years" The New York Times 18 March 2004: A1.
  15. Wang, J., Goodger, N.M., Pogrel, M.A. "Bisphosphonate-Associated Osteonecrosis of the Jaws: Impact on Oral Health." Journal of Oral Maxillofacial Surgery 31.05 (2003): 1104-1107.
  16. Fleisch H. "Bisphosphonates- History and Experimental Basis." Bone 8 (1987): 523-28.
  17. Fleisch H. "Bisphosphonates: Pharmacology and Use in the Treatment of Tumour-Induced Hypercalcaemic and Metastatic Bone Disease" Drugs 42.6 (1991): 919-944.
  18. Licata A.A. "Discovery, Clinical Development, and Therapeutic Uses of Bisphosphonates." Ann. Pharmacother 39 (2005): 688-677.
  19. Bamias, A., Kastritis, E., Bamia, C., et al. "Osteonecrosis of the Jaw In Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors." Journal of Oral and Maxillofacial Surgery 64.6 (June 2006): 995-996.
  20. Migliorati, C.A., Casiglia, J., Esptein, J., et al. "Managing the Care of Patients with Bisphosphonate-Associated Osteonecrosis: and American Academy of Oral Medicine Position Paper." Journal of the American Dental Association 136.12 (2005): 1658-1668.
  21. Odvina, C.V., Zerwekh, J.E., Rao, D.S., et al. "Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy." Journal of Clinical Endocrinologic Metabolism 90 (2005): 1294-1301.
  22. Gibbs, S.D.J, O'Grady, J., Seymour, J.F., Prince, H.M. "Bisphosphonate-Induced Osteonecrosis of the Jaw Requires Early Detection and Intervention." Medical Journal of Australia 183.10 (2005): 549-556.
  23. Frith, J.C., Monkkonen, J., Blackburn, G.M., Russell, R.G., Rogers, M.J. "Clodronate and Liposome-Encapsulated Clodronate Are Metabolized To a Toxic ATP Analog, Adenosine 5'-(beta, gamma-dichloromethylene) Triphosphate, By Mammalian Cells In Vitro." Journal of Bone and Mineral Research 12 (1997): 1358-67.
  24. Van Beek, E.R., Cohen, L.H., Leroy, I.M., Ebetino, F.H., Lowik, C.W., Papapoulos, S.E. "Differentiating the Mechanisms of Antiresorptive Action of Nitrogen Containing Bisphosphonates." Bone 33.5 (Nov. 2003): 805-811.
  25. Van Beek, E., Lowik, C., Van der Pluijm, G., Papapoulos, S. "The Role of Geranylgeranylation in Bone Resorption and its Suppression By Bisphosphonates in Fetal Bone Explants In Vitro: A Clue to the Mechanism of Action of Nitrogen-Containing Bisphosphonates." Journal of Bone and Mineral Research 14 (1999): 722-729.
    http://www.wikipedia.org/wiki/Bisphosphonates.
  26. "Statement by Merck & Co., Inc. Regarding FOSAMAX (alendronate sodium) and Rare Cases of Osteonecrosis of the Jaw" Product News. Merck & Co., Inc. www.merck.com/newsroom/press_releases/product/fosamax_statement.html.
  27. Pringle, Evelyn. "Fosamax Does More Harm Than Good." Information Liberation 18 April 2006.
  28. Kelleher, Susan. "Disease Expands Through Marriage of Marketing and Machines" The Seattle Times 26-30 June 2005. http://www.seattletimes.nwsource.com/html/health/sick3.html.
  29. "Free Reign for Drug Ads." Consumer Reports February 2003. http://www.consumerreports.org/cro/health-fitness/drugs-supplements/
    drug-ads-203/overview/index.htm.
  30. Freeman, Liz. "Lawsuit Claims Fosamax Caused Tissue Disease." Naples News 16 April 2006. http://www.naplenews.com/news/2006/apr/15/lawsuit_cliams_fosamax_
    caused_tissue_disease/?local_news
  31. "Long-Term Results of Taking Fosamax." Healthfacts April 2004. http://www.findarticles.com/p.articles/mi_m0815/is_4_29/ai_n6134055.
  32. Schneider, Jennifer P. "Should Bisphosphonates Be Continued Indefinitely? An Unusual Fracture in a Healthy Woman on Long-Term Alendronate." Geriatrics Jan 2006. http://www.findarticles.com/p.articles/mi_m2578/is_1_61/ai_ai_n16519875.
  33. Ensrud, K.E., et al. "Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Resulst From the Fracture Intervention Trial Long-Term Extension" Journal of Bone and Mineral Research 20.6 (June 2005): 895-897.
  34. "Fosamax…Not So Great At Reducing Hip Fracture." Healthfacts August 2005.
  35. Ott, Susan M. "Bisphosphonates." Osteoporosis and Bone Physiology. 2006. The University of Washington Department of Medicine. 2006. http://courses.washington.edu/bonephys/opbis.html.
  36. "Bone Density Testing New Recommendation for When to Start." Healthfacts March 2003. http://www.findarticles.com/p/articles/mi_m0815/is_3_28/ai_98484536.